Neuroblastoma (NB) is the most common extracranial solid neoplasm seen in infancy (1). However, despite improved diagnostic and therapeutic modalities, NB is still associated with very poor prognosis (1, 2). Approximately 15% of all childhood cancer deaths are caused by NB (1). Interestingly, however, this neuroectodermal tumor is characterized by the second highest spontaneous regression rate of human malignant disorder (1, 3). While some authors suggest that growthcontrolling or apoptotic mechanisms are responsible for the observed phenomen (1, 4, 5) , others favor immunological factors such as the action of natural killer cells or specific antibodies that lead to tumor regression (1, [6] [7] [8] . Recently, the existence of natural IgM antibodies cytotoxic for human NB cells was reported in gestational sera during the second and third trimenon (9) .
In this study, we surveyed normal human serum (NHS) of 94 healthy adult individuals of both genders for cytotoxicity against NB cell lines. Approximately one-third of all tested sera exhibited considerable cytotoxicity (40% to 95% cell killing) that was mediated by natural IgM and the classical pathway of complement. The natural IgM recognized a 260-kDa antigen
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. on human NB cell lines. The antigen was also found to be expressed in vivo in a tumor of a NB patient and in human NB tumors grown in nude rats. Most interestingly, the analysis of sera from NB patients with active disease revealed the absence of the cytotoxic activity against NB, suggesting an important role of natural IgM antibodies in the defense against human NB.
MATERIALS AND METHODS
Human Cell Lines. Human NB cell lines were obtained from R. C. Seeger (LA-N-1, LA-N-5; University of California, Los Angeles) (10) , N.-K. V. Cheung (NMB-7; Memorial SloanKettering Cancer Center, New York) (11), C. Schaller (SH-SY5Y; University of Hamburg) (12) , and the American Type Culture Collection (ATCC; SK-N-SH, IMR-32, SK-N-MC).
The human melanoma cell lines SK-MEL-170 and SK-MEL-93-2 have been described (13, 14) . K562, CEM, TE-85, and RD cells were from ATCC, WiDr (15) and Panc Tu-I cells (16) were from H. Kalthoff Immunohistochemistry. Cryostat sections (5 ,tm) of subcutaneously grown human NB from nude rats or from a human NB patient were air-dried and fixed in chloroform-acetone (23) . Immunostaining of tissue sections was done with NHS at a 1:10 (vol/vol) dilution in DPBS containing 0.1% (wt/vol) bovine serum albumin for 120 min. After three washes in the same buffer; the fluorescent Cy3-conjugate was added for 60 min. After postfixation with formaldehyde, counterstaining of the nuclei was performed with hematoxylin as described (23) . The preparations were examined with a microscope (Zeiss) equipped for epifluorescence.
Other Methods. SDS/PAGE was performed in a minigel system (Pharmacia) (24) . Immunoblotting of cell membrane extracts or IgM fractions after separation on 7% (wt/vol) or 4-20% (wt/vol) gradient SDS/PAGE and electrophoretic transfer (120 min at 50 V) onto polyvinylidene difluoride membrane (Millipore) in 3-(cyclo-hexylamino)-propyl sulfonic acid transfer buffer were performed according to established procedures (25) . Cell membranes were extracted as described (14) . The possible involvement of antibodies against blood group determinants was ruled out by preabsorption on test erythrocytes of various specificities (ABO, Rh, MNS, P, Lewis, Lutheran, Kell, Duffy, Kidd, Sex-linked; Baxter, Unterschleiss-' heim, Germany). Lectin blots were performed with a glycan detection system as described by the manufacturer (Boehringer Mannheim). Trypsin, proteinase K, sodium periodate, and N-glycanase treatment of the NB cell membranes were performed as described (25) . Natural antibody reactivity to a-Gal was ruled out by preabsorption on rabbit erythrocytes (26) . GD2, GD3, and proteoglycan antigen 9.2.27 were ruled out as target antigens by preincubation of NB cells with monoclonal antibodies (21) (Fig. 1A) . These sera are referred to as positive as compared with negative sera with a cytotoxicity of <30%. Serial dilutions of positive sera revealed a significant cytotoxic effect up to a dilution factor of 1:16 (data not shown). The occurrence of cytotoxicity was independent of the individuals' age and gender. Two positive (>60% cytotoxicity) and two negative sera (<15% cytotoxicity) were selected for subsequent experiments. The positive sera were cytotoxic against all tested NB cell lines, although the extent of cytotoxicity was significantly lower for SK-N-MC cells as compared with the other NB cells (Fig. 1B) 1'_ poietic system, bone, colon, kidney, pancreas, and skeletal muscle (Fig. 1B) . Furthermore, no cytotoxicity was observed with cultured normal human fibroblasts, melanocytes, and epidermal keratinocytes (Fig. 1B) .
Characterization of the Anti-NB Cytotoxic Factor. The cytotoxic activity of positive sera was abolished by heat inactivation, MgEGTA treatment, and decomplementation with cobra venom factor of the sera, indicating the involvement of the classical complement pathway (Table 1) . Sensitization of NB cells with heat-inactivated positive serum at 0°C and subsequent incubation at 37°C in negative serum lead to a similar degree of cytotoxicity as observed with untreated positive serum (Table 1) , suggesting the presence of NBspecific complement-activating antibodies in the positive sera.
This assumption was confirmed by the observation that after sensitization with positive serum at 0°C, anti-Fc,u, but not anti-Fcy specific, F(ab')2 protected NB cells from complement-mediated killing in a dose-dependent fashion (Fig. 2A) (Fig. 2B) . With negative sera, neither IgM nor IgG was detectable in significant amounts on the cell surface (Fig. 2B ). These data are in accordance with the observation that IgM binding correlated with the degree of cytotoxicity (P < 0.001; r = 0.72; n = 70) (Fig. 2C) (Fig. 3A) . After further purification of the pooled IgM fractions by ion exchange chromatography, IgM was identified as the cytotoxic factor by SDS/PAGE and immunoblotting (Fig. 3B) . Chromatographic fractionation of negative serum revealed no anti-NB cytotoxic activity under identical conditions. However, a five-fold concentration of the pooled IgM fractions of negative serum led to an increase in cytotoxicity from <15% to approximately 50%, suggesting that cytotoxic anti-NB IgM is present but at a significantly lower concentration (not shown).
Cell Surface Expression of the NB Antigen. Fig. 4 shows the binding of natural human IgM to NB cells as analyzed by indirect immunofluorescence microscopy. With detached NB cells, the fluorescent staining signal was closely associated with the plasma membrane (Fig. 4A) . By changing the focus to the upper surface of the cells, a regularly clustered distribution of the staining signal became evident (Fig. 4B) . A similar plasma membrane-associated signal was obtained with adherent NB (Fig. 4E) . Using negative serum, no staining of detached or adherent NB cells was seen ( Fig. 4C and F ). In accordance with cytofluorometry, binding of IgM was not detected on the surface of detached or adherent melanoma cells (Fig. 4D and  G) .
Characterization of the NB Antigen. Anti-NB positive sera predominantly recognized a 260-kDa antigen in immunoblots of NB cell extracts (Fig. 5) . This antigen was not recognized by negative sera. Preadsorption of the positive serum with intact NB cells reduced the staining intensity of the 260-kDa NB antigen significantly, whereas preadsorption with intact melanoma cells had no effect on the staining intensity (Fig. 5) .
The recognition of the 260-kDa antigen by anti-NB IgM antibodies is susceptible to treatment of membrane extracts with proteinase K (Fig. 5, lane 4) (Fig. 6A) . IgM binding was not detectable with a negative serum, indicating that no endogenous patient IgM was present in the tumor (Fig. 6B) . Similarly, human NB tumors established subcutaneously in nude rats from two different cell lines (n = 5) were stained only by positive serum (Fig. 6C) but not by negative serum (Fig. 6D) .
Natural Anti-NB Activity in Patient Sera. (29, 30) . However, a definite assignment of the functional role of natural antibodies is still elusive. Suggestions for their importance include the primary control of invading microorganisms (29) , the clearance of immune complexes (31), and self non-self discrimination (32 (Fig. 1B) Table 2 ).
Using Western blot analysis techniques, we have identified a 260-kDa protein as target for the natural anti-NB IgM. Several analyses including periodate oxidation, N-glycanase treatment, and lectin blots suggest the absence of carbohydrates in the target protein (Fig. 5) . This is in accordance with the observation that carbohydrate blood group determinants and the a-Gal epitope, both of which have been described as targets of natural antibodies (26, 29, (27, 28) , exhibited also background natural IgM binding and cytotoxicity (Fig. 1B) . Therefore, natural anti-NB IgM appears to be different from naturally occurring IgM antibodies with specificity for GM2 that have been shown to be present in NHS (33) .
Collectively, the findings of our study provide evidence that natural humoral immunity against NB exists and is directed against a 260-kDa cell surface-associated NB protein which is expressed in vivo. Ongoing studies are aimed at characterizing the structure of the 260-kDa antigen and its possible role in clinical onset and course of NB. 
